We showed previously that activation of signaling downstream of sIgM in CLL cells resulted in down-regulation of PDCD4 (and up-regulation of its target for inhibition, eIF4A) [23]. This evidence concerns the gene PDCD4 and B-cell chronic lymphocytic leukemia.